Therapeutic Variables in Cataract Surgery
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00407017 |
Recruitment Status
:
Completed
First Posted
: December 4, 2006
Last Update Posted
: August 21, 2007
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cataract Surgery | Drug: Gatifloxacin Drug: Ketorolac LS Drug: Pred Forte Drug: Moxifloxacin Drug: Nepafenac Drug: EconoPred Plus | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Inclusion Criteria:
- Males or females scheduled to undergo cataract surgery
- Patients can be receiving monofocal IOLs only
- Likely to complete all study visits and able to provide informed consent
- Visual potential of 20/25 or better
Exclusion Criteria:
- Known contraindications to any study medication or ingredients
- Active ocular diseases or uncontrolled systemic disease
- Active ocular allergies

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00407017
United States, Florida | |
The Center for Excellence in Eye Care | |
Miami, Florida, United States, 33176 |
Principal Investigator: | William Trattler, MD | The Center For Excellence in Eye Care |
ClinicalTrials.gov Identifier: | NCT00407017 History of Changes |
Other Study ID Numbers: |
5264-T |
First Posted: | December 4, 2006 Key Record Dates |
Last Update Posted: | August 21, 2007 |
Last Verified: | August 2007 |
Additional relevant MeSH terms:
Cataract Lens Diseases Eye Diseases Moxifloxacin Gatifloxacin Methylprednisolone Hemisuccinate Prednisolone Ketorolac Nepafenac Prednisolone acetate Methylprednisolone acetate Methylprednisolone Prednisolone hemisuccinate Prednisolone phosphate Anti-Bacterial Agents |
Anti-Infective Agents Topoisomerase II Inhibitors Topoisomerase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Antineoplastic Agents Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Inflammatory Agents Antirheumatic Agents Cyclooxygenase Inhibitors |